Research map: Peripheral blood profiles reflecting progenitor lineage balance are associated with molecular response in chronic myeloid leukemia

Back to the article

Papers in this map

  1. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics · Yoshinobu Kanda · 2012 · 19329 citations · Cited by this paper
  2. Mouse Gata1 3′UTR modulates Gata1 levels to affect erythropoiesis · 2025 · Related
  3. A systematic analysis of performance measures for classification tasks · Marina V. Sokolova · 2009 · 7037 citations · Cited by this paper
  4. The rise of bone marrow organoids as next-generation models for blood formation and failure · 2026 · Related
  5. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia · Brian J. Druker · 2001 · 5299 citations · Cited by this paper
  6. Emerging paradigms in redox regulation: the role of selenoproteins in normal and malignant hematopoiesis · 2025 · Related
  7. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining · Janet D. Rowley · 1973 · 4333 citations · Cited by this paper
  8. Image-enabled cell sorting permits prospective isolation of primitive hematopoietic stem cell subsets with distinct functional potential · 2026 · Related
  9. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia · Emma Shtivelman · 1985 · 1642 citations · Cited by this paper
  10. CD20-targeted immunotherapies in B-cell malignancies: mechanistic and clinical advances · 2026 · Related
  11. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia · Andreas Hochhaus · 2020 · 1558 citations · Cited by this paper
  12. 2019 – ENDOTHELIAL CELL-DERIVED THROMBOSPONDIN-1 NEGATIVELY AFFECTS HEMATOPOIETIC FUNCTION DURING AGING · 2025 · Related
  13. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial · François‐Xavier Mahon · 2010 · 1556 citations · Cited by this paper
  14. ER-diffusion barriers exist in hematopoietic stem cell mitoses, but are not required for lysosomal asymmetric cell division · 2025 · Related
  15. Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML · Catriona H. M. Jamieson · 2004 · 1499 citations · Cited by this paper
  16. Inhibition of activated protein C anticoagulant function enhances coagulation but does not interrupt downstream mechanisms driving hemophilic arthropathy · 2026 · Related
  17. Prognostic discrimination in "good-risk" chronic granulocytic leukemia · JE Sokal · 1984 · 971 citations · Cited by this paper
  18. Cytotoxic and Genotoxic Stress Transiently Increase the Contribution of Platelet-Biased Hematopoietic Stem Cells to Platelet Production · 2026 · Related
  19. Hematopoietic stem cell: self‐renewal versus differentiation · Jun Seita · 2010 · 959 citations · Cited by this paper
  20. Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulation · 2026 · Related
  21. On evaluation metrics for medical applications of artificial intelligence · Steven Alexander Hicks · 2022 · 917 citations · Cited by this paper
  22. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. · Yuko Fujiwara · 1996 · 795 citations · Cited by this paper
  23. Transcription factors in myeloid development: balancing differentiation with transformation · Frank Rosenbauer · 2007 · 606 citations · Cited by this paper
  24. Myeloid Lineage Commitment from the Hematopoietic Stem Cell · Hiromi Iwasaki · 2007 · 390 citations · Cited by this paper
  25. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors · Stephen L. Nutt · 2005 · 326 citations · Cited by this paper
  26. Reciprocal Activation of GATA-1 and PU.1 Marks Initial Specification of Hematopoietic Stem Cells into Myeloerythroid and Myelolymphoid Lineages · Yojiro Arinobu · 2007 · 311 citations · Cited by this paper
  27. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia · Markus Pfirrmann · 2015 · 307 citations · Cited by this paper
  28. Cooperative and Antagonistic Interplay between PU.1 and GATA-2 in the Specification of Myeloid Cell Fates · Jonathan C. Walsh · 2002 · 272 citations · Cited by this paper
  29. Ghost cytometry · Sadao Ota · 2018 · 260 citations · Cited by this paper
  30. The minute chromosome (Ph1) in chronic granulocytic leukemia · Cameron J. Nowell · 1962 · 203 citations · Cited by this paper
  31. Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia · Lauren E. Caldemeyer · 2016 · 177 citations · Cited by this paper
  32. Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL · Andreas Hochhaus · 2023 · 146 citations · Cited by this paper
  33. 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia · Jane F. Apperley · 2025 · 133 citations · Cited by this paper
  34. Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis · Leonardo Campiotti · 2017 · 96 citations · Cited by this paper
  35. Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia · Naranie Shanmuganathan · 2020 · 92 citations · Cited by this paper
  36. European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission · François‐Xavier Mahon · 2024 · 68 citations · Cited by this paper
  37. In silico-labeled ghost cytometry · Masashi Ugawa · 2021 · 35 citations · Cited by this paper
  38. Prediction for sustained deep molecular response of BCR‐ABL1 levels in patients with chronic myeloid leukemia in chronic phase · Koji Sasaki · 2017 · 29 citations · Cited by this paper
  39. Innovation in hematology. Perspectives: CML 2016 · R. Hehlmann · 2016 · 25 citations · Cited by this paper

Source: OpenAlex (CC0)